Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN81314354) titled 'Phase I trial: Parexel International Ltd. Code: 20628A' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Purpose: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has end...